FLT3 and acute myeloid leukemia: In this study, we demonstrated that midostaurin, an inhibitor of FLT3, c-KIT, and other tyrosine kinases with established efficacy in patients with AML [6, 7] and ASM [10, 24], was not associated with prolonged cardiac repolarization or its related proarrhythmic effects.